Limit bets on clinical-trial outcomes being placed on prediction markets

TL;DR - This Nature commentary calls for limits on prediction-market bets tied to clinical-trial outcomes. With only the title provided, its specific rationale and proposed safeguards cannot be determined.

• The focus is wagering on whether clinical trials will succeed or fail.
• The article advocates restrictions rather than describing experimental research results.
• The issue matters because such markets could create financial incentives around sensitive medical outcomes.
• No evidence, policy mechanism, or recommended limit is included in the supplied content.